Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
about
Temozolomide for children and adolescents with diffuse intrinsic pontine gliomaK27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasRadiotherapy for diffuse brainstem glioma in children and young adultsDIPG in Children - What Can We Learn from the Past?Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine GliomaFuture Clinical Trials in DIPG: Bringing Epigenetics to the ClinicSpatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeuticsIn vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine gliomaDiffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic TargetsSurvival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteriaHistopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.Long-term survival of an infant with diffuse brainstem lesion diagnosed by prenatal MRI: a case report and review of the literature.A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors.A novel magnetic resonance imaging segmentation technique for determining diffuse intrinsic pontine glioma tumor volume.Human pontine glioma cells can induce murine tumors.Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture.Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain InhibitionCommon mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders.Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhoodBereaved parents' intentions and suggestions about research autopsies in children with lethal brain tumors.ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesDiffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).18 F-FDG PET standard uptake values of the normal pons in children: establishing a reference value for diffuse intrinsic pontine glioma.Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells.Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal diseaseChildren are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology.Diffuse intrinsic pontine glioma: a reassessment.Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
P2860
Q24200164-9D0284D5-9E5C-4EA4-9EA5-28E0F4C6B450Q24615283-011662FB-7A7E-41C7-90B9-8FE482EF79B5Q26471433-BDE6DE0A-A723-4625-980F-16B969FBC7BCQ26777843-54EF1B9B-42A0-43BF-9873-89C3B5324E5FQ26801528-4C860A8C-38E2-4AE0-9483-45500B4652B4Q26801858-3F32DBA5-F00D-4CA1-B38C-BEF4B28B0A6BQ27317083-BB1371F8-7986-45B6-87DB-78842225F96EQ28487205-144C8154-CC41-4915-8904-10F2452F9986Q30251385-AB000D20-3F49-4839-8564-8672B7E49B3FQ30829348-8745488E-528E-4F3E-9D77-B76ADE7C0EFCQ30837732-9ED5D356-28D3-4F16-9A0A-2A1ED5115690Q31048538-2984E47C-4BFE-412A-974F-1A6F9A579EA3Q33428049-6B02DDB3-A89C-4855-BFDD-A4FB2AC5BA5FQ33638790-E7FF0814-F4EA-43EE-B8E9-75EC0CAB64CCQ33706579-24D1ABD7-163D-4938-8C23-C9495244C0E9Q33874889-5AEAAE61-A93D-4C4B-9DD9-91F88C8BA1F5Q34054150-E6877E7A-87B3-41B6-84E8-7CD114BBF6A3Q34291274-C73F5AA7-35AA-44FD-81FC-B98E21007AEFQ34359662-0F918DBB-65E3-41E2-846A-81087C910BA8Q35828522-DF52AD10-B77E-4163-9CA1-0496923D2646Q36130555-6892203F-E2E9-4E77-BCD3-E3630F8061CBQ36578816-190CE720-2223-4046-8C02-CD3364384E03Q36705927-8FF41218-1516-49AC-82FC-2DB48E48981DQ36866043-1739759A-CA14-42EE-A4B8-B5FA94963686Q36876192-F3ED9373-2222-41B2-8D4F-354676EBC604Q36918220-C8FC672D-27DA-41BC-9C36-F20E18E2070EQ37213305-ADDBA642-B075-4D7E-ADD5-CC951D0BFFBEQ37369556-A12F6820-D698-432E-93D4-E17214C1AB5AQ37542423-9F2CF26E-5DEF-4A8B-9741-8BFE818FD856Q37635839-3BA0E497-765E-463B-8EA9-6411C94DB424Q37729676-5CCC535F-14D6-461F-B6A1-EE9216E02CAAQ37736041-FCF1466C-811D-479F-948D-BCCC3EAC4FD9Q38160149-8602B256-ACF4-4063-A587-87E6F5B39A97Q38208998-18B2584E-5284-4911-B2AC-7ADE6DFA6F3EQ38233425-743486C6-B82C-49E3-85F7-67599593E50CQ38272867-36C0FDF7-F42B-4456-9AF8-96FC51ECEDB6Q38273428-BCE269D3-97E2-426B-B461-D1E9D73D188AQ38374138-EC1FAD27-D43F-4451-9247-EEE76677E2F9Q38928611-80FC7FDE-F02F-41D2-A560-7170BB8D7E7EQ38963434-1BA5B54C-1272-4AC4-9B73-08B26E1D20A4
P2860
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@ast
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@en
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@nl
type
label
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@ast
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@en
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@nl
prefLabel
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@ast
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@en
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.
@nl
P2093
P1476
Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology
@en
P2093
G J L Kaspers
M H A Jansen
W P Vandertop
P356
10.1016/J.CTRV.2011.06.007
P577
2011-07-20T00:00:00Z